This is the third in a series of blog posts focused on AI and clinical trials/research space, highlighting topics to be discussed at the upcoming BIO International convention on June 22-25, 2026.
AI is transforming drug discovery faster than deal structures can adapt. Traditional licensing frameworks were built for linear innovation: researcher invents, institution owns,
As artificial intelligence (AI) continues to reshape business operations, many employers are reassessing workforce needs and organizational structure. For many organizations, workforce reductions or redeployments may be unavoidable as roles evolve, processes are automated, and business models change. While some organizations may ultimately pursue involuntary reductions in force (RIFs), others are exploring whether voluntary separation
USTR Proposes Section 301 Tariffs on Brazil
On June 1, 2026, the United States Trade Representative (“USTR”) proposed under Section 301 of the Trade Act of 1974 (“Section 301”) to impose tariffs on imports of goods from Brazil due to Brazil’s practices involving digital trade and electronic payment services, unfair and preferential tariffs, anti-corruption enforcement,
With the 2026 Colorado legislative session now complete, we have a clearer view of which labor and employment bills advanced, or stalled, and which developments deserve employers’ attention. As in recent sessions, workplace legislation remained a major focus, with proposals touching on everything from collective bargaining and worker safety to wage-setting and reporting obligations.
In
Key point: Colorado has repealed and replaced the Colorado AI Act, amid years of skepticism from industry critics.
On May 14, Colorado Governor Jared Polis signed SB 26-189 into law, repealing and replacing the landmark Colorado Artificial Intelligence Act (CAIA), just under two months before it was set to take effect. CAIA was enacted in
There is a lot of talk these days about how the artificial intelligence (AI) boom will revolutionize the economy. The electric power sector is no exception. All over the country, tech companies are developing hyperscale data centers to provide the computing power necessary for cloud-based services, large language model training, and other AI applications. These
This is the second in a series of blog posts focused on AI and clinical trials/research space, highlighting topics to be discussed at the upcoming BIO International convention on June 22-25, 2026.
Introduction
Your latest trial sponsor is using AI to accelerate protocol development and patient recruitment,[1] cutting timelines that once took months
Register for our webinar, AI in Your Organization: Are Your Contracts Keeping Up?, on May 19 at noon CT, presented by Kris Kappel and Maggie Mannebach.
Artificial intelligence is no longer an emerging technology—it is embedded in the mainstream enterprise software, platforms, and vendor services that organizations rely on every day. In many cases,
For years, the Investment Tax Credit (ITC) under Section 48 and the Production Tax Credit (PTC) under Section 45 of the Internal Revenue Code provided the federal tax incentive foundation for biogas electricity projects.
This is the first in a series of blog posts focused on AI and clinical trials/research space, highlighting topics to be discussed at the upcoming BIO International convention on June 22-25, 2026.
A major research institution combines 15 years of patient genomic data with metabolomic profiles and clinical outcomes, feeding it into an AI model